Pilot Study of Interleukin-2 and Lymphokine-Activated Killer Cells Combined With Immunomodulatory Doses of Chemotherapy and Sequenced With Interferon Alfa-2a in Patients With Metastatic Melanoma and Renal Cell Carcinoma
Sznol, M., Clark, J. W., Smith, J. W., Steis, R. G., Urba, W. J., Rubinstein, L. V., VanderMolen, L. A., Janik, J., Sharfman, W. H., Fenton, R. G., Creekmore, S. P., Kremers, P., Conlon, K., Hersey, JVolume:
84
Language:
english
Journal:
JNCI Journal of the National Cancer Institute
DOI:
10.1093/jnci/84.12.929
Date:
June, 1992
File:
PDF, 881 KB
english, 1992